Beranda › Limfadenopati Immunoblastik › New York › New York City
Uji klinis Limfadenopati Immunoblastik di New York City, NY
5 studi untuk Limfadenopati Immunoblastik mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Columbia University, New York
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Menerima pesertaFase 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Menerima pesertaFase 3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Menerima pesertaFase 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Registry for People With T-cell Lymphoma
Menerima pesertaStudi observasional
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Uji klinis Limfadenopati Immunoblastik di kota lain
- Durham, NC4 studi
- Houston, TX4 studi
- Chicago, IL4 studi
- Miami, FL4 studi
- Rochester, MN3 studi
- New Haven, CT3 studi
- Boston, MA3 studi
- Atlanta, GA3 studi
- Columbus, OH3 studi
- Edison, NJ3 studi
- Baldwin Park, CA3 studi
- St. Louis, MO3 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.